VR Logo

Jenburkt Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1985

Chairman: Ashish U Bhuta

Managing Director: Ashish U Bhuta

Group: --

Listing: BSE: 524731

Headquarters: Mumbai, Maharashtra

Website: www.jenburkt.com

Key Facts

Market cap: R 174.58 Cr

Revenue (TTM): R 123.74 Cr

Earnings (TTM): R 17.15 Cr

Cash: R 55.22 Cr

Total Debt: R 7.47 Cr

Promoters' ownership: 45.73%

Liquidity: Moderate

52 Week range: R 243.20 - 559.00

Face value: R10.00

Shares outstanding: 45,89,378

10 Years Aggregate:

  • CFO: 90.59 Cr
  • EBITDA: 147.81 Cr
  • Net Profit: 100.46 Cr

Stock Performance

Time Period Jenburkt Pharma. S&P BSE Healthcare S&P BSE Small Cap
YTD-6.0917.93-15.54
1 month10.763.294.22
3 months-3.4013.75-15.99
1 Year-27.1517.97-22.54
3 Years-7.454.50-8.90
5 Years1.30-0.111.33
10 Years18.1311.122.98
As on 03-Jun-2020
Year Jenburkt Pharma. S&P BSE Small Cap S&P BSE Healthcare
2019-30.80-6.85-3.55
2018-5.80-23.41-5.89
201725.5859.640.49
20167.631.77-12.88
201536.806.7615.06
2014320.1969.2447.43
201313.24-11.2322.55